Evidence Supports Validity of Seasonal Affective Disorder
Dear Editor:
We were surprised to read in a recent editorial that Dr Paul Grof questions the validity of the diagnosis of seasonal affective disorder (SAD). He writes that "the evidence for the existence of SAD itself is still missing, more than 20 years after it was proposed. In clinical course, genetic, and treatment studies, there is still no convincing justification for the diagnosis of an independent seasonal illness" (1, p 124). This statement seems based more on idiosyncratic opinion than on scientific evidence. First, it is worth clarifying that the DSM-IV classifies SAD as a seasonal pattern specifier for major depressive disorder (MDD) (2), and hence, it is regarded as a subtype of depression rather than an independent diagnostic category. Second, there is ample evidence to demonstrate that seasonal pattern is a valid specifier for MDD and that light therapy is an effective treatment for SAD. Since the condition was first described in 1984, nearly 1000 articles have been indexed on Medline under the heading, "seasonal affective disorder." Indeed, extensive reviews support an argument that there is more evidence for the validity of SAD than for many other well-recognised depressive subtypes, including bipolar II disorder, atypical depression, and postpartum depression (3, 4) . SAD and its treatment have also been comprehensively reviewed and included in Canadian (5), American (6) , and international (7) evidence-based guidelines for the treatment of depressive disorders. We suggest that it is time to leave behind the argument of whether SAD is a valid diagnosis and concentrate instead upon determining the pathophysiology and most effective methods of identifying and treating this prevalent and disabling subtype of depression.
Reply: Evidence Supports Validity of Seasonal Affective Disorder
Let me thank Dr Michalak and Dr Lam for bringing to our attention an issue of major clinical importance-seasonal affective disorder (SAD). To illustrate the potential significance of such a disorder: if it were proven to recur consistently in the same season it could be treated intermittently, without exposing patients to the well-known adverse effects of chronic pharmacotherapy.
Dr Michalak and Dr Lam express surprise that I do not share their belief in SAD as a distinct subtype. The reason is simple, as I mentioned in my editorial: "In clinical course, genetic, and treatment studies, there is still no convincing justification" (1, p 124) for such an entity-and I am in good company when I conclude that SAD remains an elusive fiction (2, 3) .
A striking seasonality of episode onsets certainly exists for groups of patients with mood disorders, but individuals who experience recurrences in the same season for a few years lose this pattern later. The database from an international study of 1309 patients, developed and published before the present enchantment with SAD, shows that individual patients do not experience recurrences in the same season more often than might be expected by chance (4) . Further, there is not a single patient in the study with recurrences continuing in the same season over the lifetime. Studies demonstrating that patients who initially meet the SAD criteria continue meeting them over time, are also missing in the literature.
To defend their belief, Dr Michalak and Dr Lam refer to what they consider to be indisputable authorities: the DSM-IV (5) and the International Guidelines (6) . However, the DSM-IV committees refused to recognize SAD as an entity,
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